AOD-9604 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-11-28. Numbers and descriptions here follow the published literature rather than marketing material.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA under peptide hormones |
| WADA class | S2 | Peptide hormones, growth factors, related substances, and mimetics |
| Approved therapeutic use | Not established | Clinical research did not lead to broad marketing approval |
| Common detection method | LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| Sample preparation | Extraction and enrichment | Immunoaffinity or solid-phase extraction may be used |
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
==== E ==== Elenski but – a dry-cured ham from the town of Elena in northern Bulgaria and a popular delicacy throughout the country. The meat has a specific taste and can be preserved in the course of several years, owing much to the special process of making and the climatic conditions of the part of Stara Planina where Elena is located.
The Vietnam National Games (Vietnamese: Đại hội Thể thao toàn quốc, lit. 'National Sports Games') is a major national multi-sport event normally held in Vietnam once every four years (previously once held every five years from 1985 to 1995), organised by the Sports Authority of Vietnam (Vietnamese: Cục Thể Dục thể thao Việt Nam, lit. 'Vietnam Department of Physical Education and Sports'). The inaugural Games took place in 1985 in Hanoi, and the most recent was held in 2022 in Quảng Ninh. Almost every sports delegations representing provinces, cities, ministries, and sectors that have participated in the Games throughout history have won at least one medal in every edition, except for four delegations: Hà Tuyên, Nam Hà, Nghĩa Bình và Thuận Hải, which have never won any medals; these were all former provinces that have now been dissolved, forming eight successor administrative units: Hà Giang and Tuyên Quang (separated from Hà Tuyên), Nam Định and Hà Nam (separated from Nam Hà), Quảng Ngãi and Bình Định (separated from Nghĩa Bình), Bình Thuận and Ninh Thuận (separated from Thuận Hải). After becoming independent, these provinces continued to send athletes to participate as separate sports delegations, and it was from this point that they began to achieve their first significant successes. The Games have been held in 5 provinces & cities: five times in Hanoi (1985, 1990, 1995, 2002, 2018), and once each in Đà Nẵng (2010), Nam Định (now Ninh Bình) (2014), Quảng Ninh (2022), and Ho Chi Minh City (2006).
Victoria confronts her father, General Byng, about the town's problems, and he instructs her to start taking her Joy again and check in on Dr. Verloc at Haworth Labs, where he is working on a permanent replacement for Joy. However, her progress is halted by a strike by the lab workers, who demand that Sally be reinstated to her position in the lab. After helping suppress the strike, Victoria confronts Dr. Verloc. Realizing that Dr. Verloc has no permanent solution and is willing to let the populace die off to "sustainable" levels, Victoria resolves to cut off the town's Joy supply to wean them off the drug. In order to achieve these, she destroys both the pill allocator and water treatment plant responsible for distributing Joy throughout the town. She is arrested and thrown in jail, where she remembers how her mother was imprisoned in India for supporting Indian independence from Britain. General Byng helps her escape, and informs her about his safe house where he has stockpiled supplies and an escape boat. Shocked at her father's cowardice and willingness to abandon the town to its fate, Victoria rejects his offer and resolves to save the town. In order to permanently stop all Joy production, she demolishes Haworth Labs, narrowly escaping its destruction. The combination of the destruction of the Joy supply and the broadcast of Uncle Jack's final recording sends Wellington Wells into complete anarchy as the enraged citizens slaughter each other.
During the 1971–72 season, she co-starred as barmaid Ruth in Nichols, a James Garner–led Western, which aired 22 episodes on NBC. During an August 3, 1970, interview on The Dick Cavett Show, Kidder stated that she was ambivalent toward having a film career, and was considering working as a film editor in the future. At this time, she had become an acquaintance of director Robert Altman, and served as an apprentice assisting him in editing Brewster McCloud (1970). She subsequently appeared in "Such Dust As Dreams Are Made On", the first pilot for Harry O, which aired in March 1973. She was a guest star in a 1972 episode of the George Peppard detective series Banacek. After moving to Los Angeles, Kidder was cast opposite Gene Wilder in Quackser Fortune Has a Cousin in the Bronx (1970) as an exchange student in Ireland who becomes the love interest of a poor horse manure collector in Dublin, whom she almost runs over with her car. After filming in Ireland, Kidder relocated to New York City to study acting further. A year later, she returned to California, and was cast in the Brian De Palma film Sisters (1972), which gained notoriety for both the director and Kidder, who as leading lady, portrayed conjoined twins, one of whom is a suspect in a brutal murder. Kidder had been in a relationship with De Palma at the time, and had been roommates with co-star Jennifer Salt in Los Angeles.
Brilliant blue FCF (Blue 1) is a synthetic organic compound used primarily as a blue colorant for processed foods, medications, dietary supplements, and cosmetics. It is classified as a triarylmethane dye and is known under various names, such as FD&C Blue No. 1 or acid blue 9. It is denoted by E number E133 and has a color index of 42090. It has the appearance of a blue powder and is soluble in water and glycerol, with a maximum absorption at about 628 nanometers. It is one of the oldest FDA-approved color additives, having been permanently listed for use in food and ingested drugs in 1969. It is generally considered nontoxic and safe for consumption.
Sources: en.wikipedia.org
No evidence for lawrencium being volatile was obtained and the lower limit for the enthalpy of adsorption of lawrencium on quartz or platinum was significantly higher than the estimated value for the s2p configuration.
{\displaystyle \int _{V}{\frac {\partial E}{\partial t}}\,dV=-\oint _{\partial V}E{\mathbf {v} }\cdot d{\mathbf {A} }+\oint _{\partial V}({\mathbf {\sigma } \cdot v})\cdot d{\mathbf {A} }-\oint _{\partial V}{\mathbf {q} }\cdot d{\mathbf {A} }}
=== Parliaments of the Union === 1st South African Parliament (1910–1915) – majority party: South African Party 2nd South African Parliament (1915–1920) – majority party: South African Party 3rd South African Parliament (1920–1921) – majority party: South African Party 4th South African Parliament (1921–1924) – majority party: South African Party 5th South African Parliament (1924–1929) – majority party: National Party 6th South African Parliament (1929–1933) – majority party: National Party 7th South African Parliament (1933–1938) – majority party: United Party 8th South African Parliament (1938–1943) – majority party: United Party 9th South African Parliament (1943–1948) – majority party: United Party 10th South African Parliament (1948–1953) – majority party: National Party 11th South African Parliament (1953–1958) – majority party: National Party 12th South African Parliament (1958–1961) – majority party: National Party
Protein synthesis, as any other of the 20 proteinogenic amino acids Lipid synthesis, especially by cancer cells. Regulation of acid-base balance in the kidney by producing ammonium Cellular energy, as a source, next to glucose Nitrogen donation for many anabolic processes, including the synthesis of purines Carbon donation, as a source, refilling the citric acid cycle Nontoxic transporter of ammonia in the blood circulation.
Sources: en.wikipedia.org
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.
Confirmatory detection typically uses liquid chromatography with mass spectrometry. Immunoassays may be used for screening, but mass spectrometry provides structural confirmation.
No widely approved therapeutic indication exists for AOD-9604. It has been investigated in clinical studies, but regulatory approvals for general medical use are not established.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.